Thumbnail
Access Restriction
Open

Author Engdahl, Johan ♦ Svennberg, Emma ♦ Friberg, Leif ♦ Al-Khalili, Faris ♦ Frykman, Viveka ♦ Katrin, Kemp Gudmundsdottir ♦ Fredriksson, Tove ♦ Rosenqvist, Mårten
Source Paperity
Content type Text
Publisher Oxford University Press
File Format PDF ♦ HTM / HTML
Copyright Year ©2017
Abstract Atrial fibrillation (AF) is the most prevalent clinical arrhythmia and a major risk factor for ischaemic stroke. Treatment with oral anticoagulants (OACs) reduces the risk of stroke by two thirds in AF patients with risk factors. Due to its often paroxysmal and asymptomatic presentation, AF is sometimes challenging to diagnose. So far, AF screening studies have applied opportunistic or systematic screening, most often using a single 12-lead electrocardiogram (ECG) recording or ambulatory ECG. We hypothesise that the biomarker N-terminal pro b-type natriuretic peptide (NT-proBNP) is a valuable adjunct in population based AF screening.
ISSN 10995129
Learning Resource Type Article
Publisher Date 2017-02-01
e-ISSN 15322092
Journal EP Europace
Volume Number 19
Issue Number 2